Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$79.73

1.36 (1.74%)

05:23
12/07/18
12/07
05:23
12/07/18
05:23

Piper remains buyers of Alnylam following recent weakness

Alnylam Pharmaceuticals' R&D day highlighted the the transition into a commercial stage company with multiple late stage programs, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Alnylam is expanding RNAi drug discovery outside of the liver into central nervous system and cardiovascular disease, adds the analyst. He says Piper remains buyers of Alnylam on recent weakness ahead of new RNAi drug approvals and data read-outs. Tenthoff reiterates an Overweight rating on the stock with a $160 price target.

ALNY Alnylam
$79.73

1.36 (1.74%)

11/07/18
PIPR
11/07/18
NO CHANGE
Target $160
PIPR
Overweight
Alnylam weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff remains a buyer of Alnylam Pharmaceuticals on weakness after the company reported initial Onpattro Q3 sales of $460,000, below his $3M estimate. The initial launch metrics and advantageous commercial profile versus Tegsedi should translate into adoption, Tenthoff tells investors in a research note. 125 patient start forms submitted as of Q3, which is not the only source of demand, could translate into $11M in further Onpattro sales over the next few quarters, says the analyst. He reiterates an Overweight rating on Alnylam shares with a $160 price target.
11/15/18
STFL
11/15/18
NO CHANGE
Target $111
STFL
Buy
Alnylam management 'exudes confidence' in TTR launch, says Stifel
After hosting a dinner with Alnylam CEO John Maraganore and the company's management, Stifel analyst Paul Matteis said management "exudes confidence" that Onpattro can penetrate a substantial portion of the diagnosed haTTR population while acknowledging that it takes a little time to convert "start forms" into paying commercial patients. Management also seems "completely at ease" ahead of the full readout of the givosiran phase 3 ENVISION data, said Matteis, who keeps a Buy rating and $111 price target on Alnylam shares.
11/27/18
LEER
11/27/18
INITIATION
Target $63
LEER
Market Perform
Alnylam initiated with a Market Perform at Leerink
Leerink analyst Mani Foroohar initiated Alnylam with a Market Perform rating and a price target of $63.
11/27/18
LEER
11/27/18
INITIATION
LEER
Leerink initiates select Genetic Medicine names on increasing regulatory clarity
Leerink analyst Mani Foroohar initiated select Genetic Medicine stocks, stating that the field is "is rich with companies developing drugs" to treat rare diseases and that he is increasingly more bullish on "innovation velocity and increasing regulatory clarity in the sector. Based on his "balanced view of pricing dynamics", the analyst issues an Outperform rating on Wave Life Sciences (WVE), Rocket Pharmaceuticals (RCKT), Intellia Therapeutics (NTLA), Eidos Therapeutics (EIDX), Dicerna (DRNA) and Bluebird Bio (BLUE). The analyst likes Wave Life Sciences as a pure play on Oligotherapeutics and its stereopure chemistry platform as a differentiated approach to oligo drug design. Foroohar is positive on Rocket Pharma's lead assets in gene therapies for Fanconi Anemia and Leukocyte Adhesion Deficiency-I "which will likely be the company's first potential approved product." The analyst is positive on Intellia Therapeutics' "robust balance sheet to support development, trading at a material discount to closest comps peers". For Eidos, the analyst cites the prospects of its drug candidate for TTR amyloidosis currently in a placebo-controlled Phase 2 study that may offer a competitive profile relative to Pfizer's (PFE) tafamidis. For Dicerna, Foroohar notes that its DCR-PHXC "is an RNAi therapeutic that targets lactate dehydrogenase A for the treatment of all subtypes of Primary Hyperoxaluria vs. competitor Alnylam's (ALNY) lumasiran, which only treats PH Type 1. For Bluebird Bio, the analyst is positive on its position as a "leader in ex vivo gene therapy, with four programs with visibility towards near-term regulatory approval". Foroohar initiates Avrobio (AVRO), Alnylam (ALNY), and Ionis Pharmaceuticals (IONS) with Market Perform rating based on competitive launches for their products along with "mixed" early signs of their results. The analyst also rates Regenxbio (RGNX) at underperform, saying that its "current valuation more than accounts for robust royalty streams from sales in spinal muscular atrophy" and other partnered assets.

TODAY'S FREE FLY STORIES

PCG

PG&E

$23.30

1.84 (8.57%)

, BRK.A

Berkshire Hathaway

$316,942.57

-177.43 (-0.06%)

10:21
04/24/19
04/24
10:21
04/24/19
10:21
Periodicals
SparkSpread confirms Berkshire denies talks to acquire PG&E »

Noting that PG&E…

PCG

PG&E

$23.30

1.84 (8.57%)

BRK.A

Berkshire Hathaway

$316,942.57

-177.43 (-0.06%)

BRK.B

Berkshire Hathaway

$211.07

-0.66 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 04

    May

USO

United States Oil Fund

$13.78

-0.01 (-0.07%)

10:20
04/24/19
04/24
10:20
04/24/19
10:20
Options
Put spreads in US Oil Fund after big gains in shares »

Put spreads in US Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
04/24/19
04/24
10:17
04/24/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
04/24/19
04/24
10:16
04/24/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$60.18

-2.17 (-3.48%)

, APC

Anadarko

$71.42

7.3 (11.38%)

10:15
04/24/19
04/24
10:15
04/24/19
10:15
Recommendations
Occidental Petroleum, Anadarko, Chevron analyst commentary at Raymond James »

Raymond James says…

OXY

Occidental Petroleum

$60.18

-2.17 (-3.48%)

APC

Anadarko

$71.42

7.3 (11.38%)

CVX

Chevron

$120.00

-2 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

10:15
04/24/19
04/24
10:15
04/24/19
10:15
General news
Breaking General news story  »

Week of 4/19 EIA…

LULU

Lululemon

$175.89

-0.94 (-0.53%)

, NKE

Nike

$87.92

0.51 (0.58%)

10:14
04/24/19
04/24
10:14
04/24/19
10:14
Hot Stocks
Lululemon CEO says has tested footwear, plans to enter the market »

CEO Calvin McDonald…

LULU

Lululemon

$175.89

-0.94 (-0.53%)

NKE

Nike

$87.92

0.51 (0.58%)

ADDYY

Adidas

$0.00

(0.00%)

FL

Foot Locker

$61.08

0.84 (1.39%)

UA

Under Armour

$20.14

0.21 (1.05%)

UAA

Under Armour

$22.66

0.28 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

  • 02

    May

  • 09

    May

  • 09

    May

  • 22

    May

  • 24

    May

FTDR

Frontdoor

$33.93

0.24 (0.71%)

, PLCE

Children's Place

$110.70

0.78 (0.71%)

10:12
04/24/19
04/24
10:12
04/24/19
10:12
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FTDR

Frontdoor

$33.93

0.24 (0.71%)

PLCE

Children's Place

$110.70

0.78 (0.71%)

TRGP

Targa Resources

$40.49

-0.43 (-1.05%)

DOOO

BRP Inc.

$31.83

(0.00%)

PII

Polaris Industries

$98.28

0.51 (0.52%)

TRWH

Twin River Worldwide

$33.00

0.43 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 07

    May

  • 08

    May

HOG

Harley-Davidson

$37.98

-0.94 (-2.42%)

, TSEM

TowerJazz

$17.81

0.08 (0.45%)

10:12
04/24/19
04/24
10:12
04/24/19
10:12
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HOG

Harley-Davidson

$37.98

-0.94 (-2.42%)

TSEM

TowerJazz

$17.81

0.08 (0.45%)

MAR

Marriott

$135.45

-0.83 (-0.61%)

KHC

Kraft Heinz

$32.56

-0.53 (-1.60%)

H

Hyatt

$76.17

-0.35 (-0.46%)

HLT

Hilton

$87.57

-0.33 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 15

    May

  • 15

    May

  • 28

    May

  • 29

    May

LLY

Eli Lilly

$117.48

-0.03 (-0.03%)

, SNAP

Snap

$11.28

-0.71 (-5.92%)

10:12
04/24/19
04/24
10:12
04/24/19
10:12
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

LLY

Eli Lilly

$117.48

-0.03 (-0.03%)

SNAP

Snap

$11.28

-0.71 (-5.92%)

BBY

Best Buy

$74.99

1.39 (1.89%)

PG

Procter & Gamble

$103.85

0.66 (0.64%)

SON

Sonoco

$62.34

1.025 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 23

    May

  • 29

    May

  • 18

    Jul

  • 17

    Oct

LCNB

LCNB Corp.

$16.45

(0.00%)

10:11
04/24/19
04/24
10:11
04/24/19
10:11
Hot Stocks
LCNB Corp. announces 500,000 share repurchase program »

LCNB Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

APH

Amphenol

$100.13

-5.27 (-5.00%)

10:10
04/24/19
04/24
10:10
04/24/19
10:10
Recommendations
Amphenol analyst commentary at Morgan Stanley »

Amphenol selloff a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 22

    May

PHM

PulteGroup

$31.61

0.27 (0.86%)

10:10
04/24/19
04/24
10:10
04/24/19
10:10
Options
Call spreads in Pulte Homes after a 3.7% earnings day move yesterday »

Call spreads in Pulte…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

DOMO

Domo

$38.79

1.87 (5.07%)

10:09
04/24/19
04/24
10:09
04/24/19
10:09
Options
Domo calls active as shares see strength »

Domo calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$103.29

0.23 (0.22%)

, TSN

Tyson Foods

$74.60

0.15 (0.20%)

10:08
04/24/19
04/24
10:08
04/24/19
10:08
Periodicals
Walmart, bypassing Tyson, creates Angus beef supply chain, Bloomberg reports »

Bypassing Tyson Foods…

WMT

Walmart

$103.29

0.23 (0.22%)

TSN

Tyson Foods

$74.60

0.15 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 06

    May

  • 06

    May

  • 16

    May

  • 29

    May

  • 05

    Jun

  • 07

    Jun

  • 13

    Nov

VLO

Valero

$89.11

-1.17 (-1.30%)

10:05
04/24/19
04/24
10:05
04/24/19
10:05
Options
Valero call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

XOM

Exxon Mobil

$82.49

-0.9 (-1.08%)

10:01
04/24/19
04/24
10:01
04/24/19
10:01
Hot Stocks
Exxon Mobil to expand Fawley refinery in United Kingdom »

ExxonMobil said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RES

RPC, Inc.

$11.59

-1.31 (-10.16%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
RPC, Inc. falls -10.0% »

RPC, Inc. is down -10.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

SPN

Superior Energy

$4.42

-0.545 (-10.98%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Superior Energy falls -10.1% »

Superior Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

LRN

K12

$31.01

-5.215 (-14.40%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
K12 falls -13.7% »

K12 is down -13.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAP

SAP

$129.21

14.37 (12.51%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
SAP rises 12.5% »

SAP is up 12.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

TRK

Speedway Motorsports

$18.09

4.11 (29.40%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Speedway Motorsports rises 29.9% »

Speedway Motorsports is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

MPX

Marine Products

$15.49

1.46 (10.41%)

10:00
04/24/19
04/24
10:00
04/24/19
10:00
Hot Stocks
Marine Products rises 13.8% »

Marine Products is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

AMRN

Amarin

$18.08

-0.31 (-1.69%)

09:59
04/24/19
04/24
09:59
04/24/19
09:59
Recommendations
Amarin analyst commentary at Jefferies »

Jefferies sees potential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

  • 06

    May

APC

Anadarko

$71.16

7.04 (10.98%)

, PCG

PG&E

$22.35

0.89 (4.15%)

09:55
04/24/19
04/24
09:55
04/24/19
09:55
Options
Early notable gainers among liquid option names on April 24th »

Notable gainers among…

APC

Anadarko

$71.16

7.04 (10.98%)

PCG

PG&E

$22.35

0.89 (4.15%)

TEL

TE Connectivity

$93.81

4.01 (4.47%)

NSC

Norfolk Southern

$210.59

8.91 (4.42%)

EBAY

eBay

$38.38

1.72 (4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 07

    May

  • 09

    May

  • 14

    May

  • 22

    May

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.